Trigeminal Neuralgia: Differential Diagnoses & Workup

References

1. Osler W. The principles and practice of medicine. 8th ed. 1912:191-202.

2. Penman J. Trigeminal neuralgia. In: Vinkin PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Vol 55. 1968:296-322.

3. Mauskop A. Trigeminal neuralgia (tic douloureux). J Pain Symptom Manage. Apr 1993;8(3):148-54. [Medline].

4. Rushton JG, Olafson RA. Trigeminal neuralgia associated with multiple sclerosis. A case report. Arch Neurol. Oct 1965;13(4):383-6. [Medline].

5. Jensen TS, Rasmussen P, Reske-Nielsen E. Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta Neurol Scand. Mar 1982;65(3):182-9. [Medline].

6. Patten J. Trigeminal neuralgia. In: Neurological Differential Diagnosis. 2nd ed. London: Springer;1996:373-5.

7. Sands GH. Pain in the face. Headaches in Adults, Annual Course, American Academy of Neurology Annual Meeting. 1994;3:146:130-2.

8. Fromm GH, Terrence CF, Chattha AS, Glass JD. Baclofen in trigeminal neuralgia: its effect on the spinal trigeminal nucleus: a pilot study. Arch Neurol. Dec 1980;37(12):768-71. [Medline].

9. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain. Jan 1997;120 (Pt 1):193-209. [Medline].

10. Türp JC, Gobetti JP. Trigeminal neuralgia versus atypical facial pain. A review of the literature and case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Apr 1996;81(4):424-32. [Medline].

11. Burcheil KJ. Trigeminal neuralgia. In: Conn's Current Therapy. 1999:948-50.

12. Dalessio DJ. Trigeminal neuralgia. A practical approach to treatment. Drugs. Sep 1982;24(3):248-55. [Medline].

13. Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology. May 1997;48(5):1467. [Medline].

14. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology. Aug 1998;51(2):611-4. [Medline].

15. Solaro C, Lunardi GL, Capello E, et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology. Aug 1998;51(2):609-11. [Medline].

16. Lunardi G, Leandri M, Albano C, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. Jun 1997;48(6):1714-7. [Medline].

17. Carrazana EJ, Schachter SC. Alternative uses of lamotrigine and gabapentin in the treatment of trigeminal neuralgia. Neurology. Apr 1998;50(4):1192. [Medline].

18. Loeser JD. The management of tic douloureux. Pain. Apr 1977;3(2):155-62. [Medline].

19. Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). Lancet. Apr 21 1962;1:839-40. [Medline].

20. Raskin NH. Trigeminal neuralgia. 2nd ed. 1988.

21. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. Nov 1997;73(2):223-30. [Medline].

22. [Best Evidence] He L, Wu B, Zhou M. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev. Jul 19 2006;3:CD004029. [Medline].

23. Parekh S, Shah K, Kotdawalla H. Baclofen in carbamazepine resistant trigeminal neuralgia - a double-blind clinical trial. Cephalalgia. 1989;9 (Suppl 10):392-3.

24. Fromm GH, Terrence CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology. Nov 1987;37(11):1725-8. [Medline].

25. Sweet WH. Percutaneous methods for the treatment of trigeminal neuralgia and other faciocephalic pain; comparison with microvascular decompression. Semin Neurol. Dec 1988;8(4):272-9. [Medline].

26. Zakrzewska JM, Thomas DG. Patient's assessment of outcome after three surgical procedures for the management of trigeminal neuralgia. Acta Neurochir (Wien). 1993;122(3-4):225-30. [Medline].

27. Meglio M, Cioni B. Percutaneous procedures for trigeminal neuralgia: microcompression versus radiofrequency thermocoagulation. Personal experience. Pain. Jul 1989;38(1):9-16. [Medline].

28. Cappabianca P, Spaziante R, Graziussi G, et al. Percutaneous retrogasserian glycerol rhizolysis for treatment of trigeminal neuralgia. Technique and results in 191 patients. J Neurosurg Sci. Mar 1995;39(1):37-45. [Medline].

29. Taha JM, Tew JM Jr. Treatment of trigeminal neuralgia by percutaneous radiofrequency rhizotomy. Neurosurg Clin N Am. Jan 1997;8(1):31-9. [Medline].

30. Kondziolka D, Lunsford LD, Flickinger JC, et al. Stereotactic radiosurgery for trigeminal neuralgia: a multi-institutional study using the gamma unit. J Neurosurg. Jun 1996;84(6):940-5. [Medline].

31. Kondziolka D, Perez B, Flickinger JC, et al. Gamma knife radiosurgery for trigeminal neuralgia: results and expectations. Arch Neurol. Dec 1998;55(12):1524-9. [Medline].

32. Leksell L. Stereotactic radiosurgery in trigeminal neuralgia. Acta Chem Scand. 1971;37:311-314.

33. Allam N, Brasil-Neto JP, Brown G, Tomaz C. Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia. Clin J Pain. Mar-Apr 2005;21(2):182-4. [Medline].

34. Gilron I, Booher SL, Rowan MS, et al. A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias. Neurology. Oct 10 2000;55(7):964-71. [Medline].

35. DMKG study group. Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J Neurol. May 2003;250(5):542-5. [Medline].

36. Aguggia M. Typical facial neuralgias. Neurol Sci. May 2005;26 Suppl 2:s68-70. [Medline].

37. Bederson JB, Wilson CB. Evaluation of microvascular decompression and partial sensory rhizotomy in 252 cases of trigeminal neuralgia. J Neurosurg. Sep 1989;71(3):359-67. [Medline].

38. Beniczky S, Tajti J, Timea Varga E, Vecsei L. Evidence-based pharmacological treatment of neuropathic pain syndromes. J Neural Transm. Jun 2005;112(6):735-49. [Medline].

39. Beydown A, et al. Meta-analysis of comparative trials of oxcarbazepine versus carbamazepine in trigeminal neuralgia. Oxcarbazepine Study Group. Poster presented at the 21st American Pain Society Annual Meeting, Baltimore, Md; Mar 14-17, 2002.

40. Bowsher D. Trigeminal neuralgia: an anatomically oriented review. Clin Anat. 1997;10(6):409-15. [Medline].

41. Brisman R. Surgical treatment of trigeminal neuralgia. Semin Neurol. 1997;17(4):367-72. [Medline].

42. Burchiel KJ. Gamma knife and trigeminal neuralgia. J Neurosurg. Mar 2005;102(3):431-2; discussion 32. [Medline].

43. Caccia MR. Clonazepam in facial neuralgia and cluster headache. Clinical and electrophysiological study. Eur Neurol. 1975;13(6):560-3. [Medline].

44. Farago F. Trigeminal neuralgia: its treatment with two new carbamazepine analogues. Eur Neurol. 1987;26(2):73-83. [Medline].

45. Gilron I, Booher SL, Rowan JS, Max MB. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol. Mar-Apr 2001;24(2):109-12. [Medline].

46. Hilton DA, Love S, Gradidge T, Coakham HB. Pathological findings associated with trigeminal neuralgia caused by vascular compression. Neurosurgery. Aug 1994;35(2):299-303; discussion 303. [Medline].

47. Jorns TP, Zakrzewska JM. Evidence-based approach to the medical management of trigeminal neuralgia. Br J Neurosurg. Jun 2007;21(3):253-61. [Medline].

48. Kanpolat Y, Ugur HC. Systematic review of ablative neurosurgical techniques for the treatment of trigeminal neuralgia. Neurosurgery. Sep 2005;57(3):E601. [Medline].

49. Product information. Tegretol, Carbamazepine. Novartis Pharmaceuticals Corporation;1998.

50. Sandell T, Eide PK. Effect of microvascular decompression in trigeminal neuralgia patients with or without constant pain. Neurosurgery. Jul 2008;63(1):93-9; discussion 99-100. [Medline].

51. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. Jan-Feb 2002;18(1):22-7. [Medline].

52. Solomon S, Lipton RB. Facial pain. Neurol Clin. Nov 1990;8(4):913-28. [Medline].

53. Tan LK, Robinson SN, Chatterjee S. Glycerol versus radiofrequency rhizotomy - a comparison of their efficacy in the treatment of trigeminal neuralgia. Br J Neurosurg. Apr 1995;9(2):165-9. [Medline].

54. Tatli M, Satici O, Kanpolat Y, Sindou M. Various surgical modalities for trigeminal neuralgia: literature study of respective long-term outcomes. Acta Neurochir (Wien). Mar 2008;150(3):243-55. [Medline].

55. Taylor JC, Brauer S, Espir ML. Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J. Jan 1981;57(663):16-8. [Medline].

56. Tomson T, Tybring G, Bertilsson L, et al. Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration. Arch Neurol. Nov 1980;37(11):699-703. [Medline].

57. Truini A, Galeotti F, Haanpaa M, Zucchi R, Albanesi A, Biasiotta A, et al. Pathophysiology of pain in postherpetic neuralgia: A clinical and neurophysiological study. Pain. Oct 25 2008;[Medline].

58. Voorhies R, Patterson RH. Management of trigeminal neuralgia (tic douloureux). JAMA. Jun 26 1981;245(24):2521-3. [Medline].

59. Waltz TA, Dalessio DJ, Copeland B, Abbott G. Percutaneous injection of glycerol for the treatment of trigeminal neuralgia. Clin J Pain. Jun 1989;5(2):195-8. [Medline].

60. [Best Evidence] Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005;CD005451. [Medline].

61. Zvartau-Hind M, Din MU, Gilani A, et al. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology. Nov 28 2000;55(10):1587-8. [Medline].

Further Reading

Keywords

trigeminal neuralgia, tic douloureux, TN, facial pain syndrome, facial pain, pain syndrome, carbamazepine therapy, carbamazepine, ICD-9 350-1, atypical facial pain, gamma knife surgery, trigeminal neuralgia symptoms, trigeminal neuralgia causes, trigeminal neuralgia treatment, trigeminal neuralgia medication, trigeminal neuralgia surgery, facial nerve pain, cranial nerve pain

Contributor Information and Disclosures

Author

Manish K Singh, MD, Assistant Professor, Department of Neurology, Teaching Faculty for Pain Management and Neurology Residency Program, Hahnemann University Hospital, Drexel College of Medicine; Medical Director, Neurology and Pain Management, Jersey Institute of Neuroscience
Manish K Singh, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Pain Medicine, American Association of Physicians of Indian Origin, American Headache Society, American Medical Association, and American Society of Regional Anesthesia and Pain Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Gordon H Campbell, MSN, Senior Nurse Practitioner, Department of Mental Health and Neuroscience, Portland Veterans Affairs Medical Center
Gordon H Campbell, MSN is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Helmi L Lutsep, MD, Professor, Department of Neurology, Oregon Health & Science University; Associate Director, Oregon Stroke Center
Helmi L Lutsep, MD is a member of the following medical societies: American Academy of Neurology and American Stroke Association
Disclosure: Co-Axia Consulting fee Review panel membership; Talecris Consulting fee Review panel membership; AGA Medical Consulting fee Review panel membership; Boehringer Ingelheim Honoraria Speaking and teaching; Concentric Medical Consulting fee Review panel membership; Abbott Consulting fee Consulting; Sanofi  Consulting

Siddharth Gautam, MBBS, Resident Physician, Jersey Neuroscience Institute
Disclosure: Nothing to disclose.

Medical Editor

Jorge E Mendizabal, MD, Consulting Staff, Corpus Christi Neurology
Jorge E Mendizabal, MD is a member of the following medical societies: American Academy of Neurology, American Headache Society, National Stroke Association, and Stroke Council of the American Heart Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

James H Halsey, MD, Professor, Department of Neurology, University of Alabama Medical Center
James H Halsey, MD is a member of the following medical societies: American Academy of Neurology, American Heart Association, American Medical Association, American Neurological Association, American Society of Neuroimaging, Medical Association of the State of Alabama, New York Academy of Sciences, Pan American Medical Association, Sigma Xi, Society for Neuroscience, and Southern Medical Association
Disclosure: Nothing to disclose.

CME Editor

Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Robert A Egan, MD, Director of Neuro-Ophthalmology, St Helena Hospital
Robert A Egan, MD is a member of the following medical societies: American Academy of Neurology, American Heart Association, North American Neuro-Ophthalmology Society, and Oregon Medical Association
Disclosure: Nothing to disclose.